BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18395441)

  • 1. Structure-activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay.
    McRobb L; Handelsman DJ; Kazlauskas R; Wilkinson S; McLeod MD; Heather AK
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):39-47. PubMed ID: 18395441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydrogestrinone is a potent androgen and progestin.
    Death AK; McGrath KC; Kazlauskas R; Handelsman DJ
    J Clin Endocrinol Metab; 2004 May; 89(5):2498-500. PubMed ID: 15126583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptive progestins. Various 11-substituents combined with four 17-substituents: 17alpha-ethynyl, five- and six-membered spiromethylene ethers or six-membered spiromethylene lactones.
    Schoonen WG; Deckers G; de Gooijer ME; de Ries R; Mathijssen-Mommers G; Hamersma H; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 2000 Oct; 74(3):109-23. PubMed ID: 11086230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
    Lemus AE; Enríquez J; García GA; Grillasca I; Pérez-Palacios G
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):121-9. PubMed ID: 9182866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins.
    García-Becerra R; Cooney AJ; Borja-Cacho E; Lemus AE; Pérez-Palacios G; Larrea F
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):21-7. PubMed ID: 15261304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nortestosterone-derived synthetic progestogens do not activate the progestogen receptor of Murray-Darling rainbowfish (Melanotaenia fluviatilis) but are potent agonists of androgen receptors alpha and beta.
    Bain PA; Kumar A; Ogino Y; Iguchi T
    Aquat Toxicol; 2015 Jun; 163():97-101. PubMed ID: 25863598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
    Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification and pharmacology of progestins.
    Schindler AE; Campagnoli C; Druckmann R; Huber J; Pasqualini JR; Schweppe KW; Thijssen JH
    Maturitas; 2003 Dec; 46 Suppl 1():S7-S16. PubMed ID: 14670641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays.
    Akram ON; Bursill C; Desai R; Heather AK; Kazlauskas R; Handelsman DJ; Lambert G
    Anal Chem; 2011 Mar; 83(6):2065-74. PubMed ID: 21329390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and application of a yeast bioassay for screening androgenic activity in calf urine and feed.
    Bovee TF; Bor G; Heskamp HH; Lasaroms JJ; Sanders MB; Nielen MW
    Anal Chim Acta; 2009 Apr; 637(1-2):225-34. PubMed ID: 19286034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of hormonal and antihormonal action of contraceptive progestins at the molecular level.
    Pérez-Palacios G; Cerbón MA; Pasapera AM; Castro JI; Enríquez J; Vilchis F; García GA; Moralí G; Lemus AE
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):479-85. PubMed ID: 1562519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 7α-methyl-19-nortestosterone effectiveness alone or combined with progestins on androgen receptor mediated-transactivation.
    García-Becerra R; Ordaz-Rosado D; Noé G; Chávez B; Cooney AJ; Larrea F
    Reproduction; 2012 Feb; 143(2):211-9. PubMed ID: 22065861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins.
    Phillips A; Demarest K; Hahn DW; Wong F; McGuire JL
    Contraception; 1990 Apr; 41(4):399-410. PubMed ID: 2335104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals.
    Deckers GH; Schoonen WG; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 2000 Oct; 74(3):83-92. PubMed ID: 11086227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorinated androgens and progestins: molecular probes for androgen and progesterone receptors with potential use in positron emission tomography.
    Brandes SJ; Katzenellenbogen JA
    Mol Pharmacol; 1987 Sep; 32(3):391-403. PubMed ID: 3499564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of contraceptive progestins and related compounds with the oestrogen receptor. Part II: Effect on (3H)oestradiol binding to the rat uterine receptor in vitro.
    van Kordelaar JM; Vermorken AJ; de Weerd CJ; van Rossum JM
    Acta Endocrinol (Copenh); 1975 Jan; 78(1):165-79. PubMed ID: 46681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications?
    Kuhl H; Wiegratz I
    Climacteric; 2007 Aug; 10(4):344-53. PubMed ID: 17653961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
    Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
    Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.
    Poulin R; Baker D; Poirier D; Labrie F
    Breast Cancer Res Treat; 1991; 17(3):197-210. PubMed ID: 1645605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha.
    Larrea F; García-Becerra R; Lemus AE; García GA; Pérez-Palacios G; Jackson KJ; Coleman KM; Dace R; Smith CL; Cooney AJ
    Endocrinology; 2001 Sep; 142(9):3791-9. PubMed ID: 11517155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.